Literature DB >> 18436660

Foot-and-mouth disease in North American bison (Bison bison) and elk (Cervus elaphus nelsoni): susceptibility, intra- and interspecies transmission, clinical signs, and lesions.

Jack Rhyan1, Ming Deng, He Wang, Gordon Ward, Thomas Gidlewski, Matthew McCollum, Samia Metwally, Thomas McKenna, Sherrilyn Wainwright, Antonio Ramirez, Charles Mebus, Mo Salman.   

Abstract

There is limited information about the pathogenesis and epidemiology of foot-and-mouth disease (FMD) in North American bison (Bison bison) or elk (Cervus elaphus nelsoni). In these two experimental infection studies, we compared the susceptibilities of bison and elk to FMD virus (FMDV), respectively, with that of cattle; determined whether intra- and interspecies transmission could occur in bison and cattle, and elk and cattle; determined suitability of conventional available laboratory tests to detect FMDV infection in bison and elk; and investigated whether bison or elk are efficient long-term carriers of FMDV. In both studies, after a period of acclimation to the containment at Plum Island Animal Disease Center, animals were infected by intraepithelial tongue inoculation with 10,000 bovine tongue infective doses of FMDV, strain O1 Manisa. Inoculated animals were kept with contact animals; subsequently, inoculated and/or exposed contact animals were placed in rooms with unexposed animals. All bison developed oral mucosal and foot lesions similar to those of cattle. Bison developed fever, lameness, inappetence, and ptyalism. Physical examinations on bison revealed numerous small vesicles and erosions affecting tongue, gingiva, muzzle, hard and soft palates, coronary bands, and interdigital skin. Inoculated elk developed transient fever and mild focal tongue and foot lesions. Contact elk developed neither clinical signs nor gross pathologic lesions of FMD. At necropsy, lesions in bison included numerous extensive vesicles, erosions, and/or ulcers in the oral cavities, feet, and rumen pillars depending on the stage of disease. Less extensive oral, foot, and rumen lesions were present in the inoculated elk. All bison and inoculated elk developed antibodies to FMDV and were positive for FMDV by reverse transcription-polymerase chain reaction (RT-PCR). Transmission occurred between cattle and bison, and bison and bison. It did not occur between elk and cattle. Elk-to-elk transmission studies resulted in only one contact elk developing serologic evidence of a subclinical infection. Other exposed elk developed neither clinical, pathologic, virologic, nor serologic evidence of disease. FMDV was not isolated from animals past 28 days postinfection.

Entities:  

Mesh:

Year:  2008        PMID: 18436660     DOI: 10.7589/0090-3558-44.2.269

Source DB:  PubMed          Journal:  J Wildl Dis        ISSN: 0090-3558            Impact factor:   1.535


  3 in total

1.  Modeling the spread and control of foot-and-mouth disease in Pennsylvania following its discovery and options for control.

Authors:  Michael J Tildesley; Gary Smith; Matt J Keeling
Journal:  Prev Vet Med       Date:  2011-12-12       Impact factor: 2.670

2.  Serotyping of foot and mouth disease virus and Pasteurella multocida from Indian gaurs (Bos gaurus), concurrently infected with foot and mouth disease and haemorrhagic septicaemia.

Authors:  Basavegowdanadoddi Marinaik Chandranaik; Raveendra Hegde; Beechagondahalli Papanna Shivashankar; Papanna Giridhar; Handenahally Kaverappa Muniyellappa; Rajeshwar Kalge; Benamanahalli Raju Sumathi; Kumble Nithinprabhu; Narasimhaiah Chandrashekara; Venkataramanappa Manjunatha; Nirupama Jaisingh; Asha Mayanna; Gowda Kallenahalli Chandrakala; Sermaraja Kanaka; Mudalagiri Dasappagupta Venkatesha
Journal:  Trop Anim Health Prod       Date:  2015-04-19       Impact factor: 1.559

3.  Rabies and canine distemper virus epidemics in the red fox population of northern Italy (2006-2010).

Authors:  Pierre Nouvellet; Christl A Donnelly; Marco De Nardi; Chris J Rhodes; Paola De Benedictis; Carlo Citterio; Federica Obber; Monica Lorenzetto; Manuela Dalla Pozza; Simon Cauchemez; Giovanni Cattoli
Journal:  PLoS One       Date:  2013-04-22       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.